Dec 11, 2018
PCMA: Setting the Record Straight on the Pennsylvania Auditor General's Medicaid Report
Nov 26, 2018
PCMA Statement on the Administration's Proposed Medicare Part D Rule
Oct 25, 2018
PCMA Statement on the Administration's Proposed Medicare Part B Pricing Model
Oct 24, 2018
PCMA Applauds the Administration for Enacting Legislation to Curb America's Opioid Crisis
Oct 15, 2018
PCMA Statement on the Administration's Proposal Requiring List Prices of Drugs in TV Ads
Oct 10, 2018
PCMA Applauds the Administration for Enacting Legislation to Ensure Patients Pay the Lowest Price for Prescription Drugs
Sep 28, 2018
PCMA Applauds Passage of Bill to Fight Opioid Epidemic
Sep 25, 2018
Labeed Diab of Humana Pharmacy Solutions Joins PCMA Board of Directors
Sep 20, 2018
PCMA Names JC Scott New President and CEO
Aug 15, 2018
New Data: Rebates are Unrelated to Drugmakers' Pricing Strategies
Jul 24, 2018
PCMA Supports Legislation to Ensure Patients Pay Lowest Price for Prescription Drugs
Jul 18, 2018
PCMA Statement on FDA Biosimilars Action Plan
Jul 16, 2018
New Research: Eliminating Drugmaker Rebates Leads to Significantly Higher Medicare Part D Premiums for Seniors
Jun 22, 2018
PCMA Applauds House Passage of Bill Curbing Opioid Epidemic
Jun 14, 2018
PCMA Applauds Judiciary Committee on Passage of CREATES Act to Help Lower Drug Prices
Jun 04, 2018
PCMA Statement on New OIG Medicare Part D Report
May 07, 2018
PCMA President and CEO Mark Merritt to Depart At Year-End
Apr 19, 2018
PCMA: New IQVIA Institute Report Shows Declining Net Spending on Prescription Drugs
Apr 11, 2018
PCMA Statement on Congressional Opioid Hearings: Pass Bipartisan E-Prescribing Legislation to Combat Crisis
Apr 03, 2018
PCMA: Trump Administration Does Not Adopt Drugmakers' Proposal to Mandate Point-of-Sale Rebates in Medicare Part D